Piccinno Emanuele, Scalavino Viviana, Labarile Nicoletta, Armentano Raffaele, Giannelli Gianluigi, Serino Grazia
National Institute of Gastroenterology S. De Bellis, IRCCS Research Hospital, Via Turi 27, 70013 Castellana Grotte, BA, Italy.
Pharmaceutics. 2024 Dec 4;16(12):1554. doi: 10.3390/pharmaceutics16121554.
BACKGROUND/OBJECTIVES: KRT23 was recently discovered as an epithelial-specific intermediate filament protein in the type I keratin family. Many studies have underlined keratin's involvement in several biological processes as well as in the pathogenesis of different diseases. Specifically, KRT23 was reported to affect the structural integrity of epithelial cells and to trigger cellular signaling leading to the onset of cancer. The aim of this study is to characterize a novel mechanism based on miR-195-5p/KRT23 in colorectal cancer.
KRT23 mRNA and protein expression were characterized in FFPE sections from patients with CRC. The effects of miR-195-5p on KRT23 expression at the mRNA and protein levels were assessed by transient transfection experiments with mimic and inhibitor molecules. Cell attachment/detachment, migration, invasion, clone formation, and apoptosis were evaluated in human CRC cell lines after miR-195-5p mimic transfection.
We identified KRT23 as a putative target of miR-195-5p, a microRNA that we previously demonstrated to be reduced in CRC. We have proved the KRT23 expression deregulation in the tumoral section compared to adjacent normal mucosa in patients with CRC, according to the data derived from the public repository. We proved that the gain of miR-195-5p decreased the KRT23 expression. Conversely, we demonstrated that the inhibition of miR-195-5p led to an increase in KRT23 expression levels. We have demonstrated the in vitro effectiveness of miR-195-5p on CRC progression and that the in vivo intraperitoneal delivery of miR-195-5p mimic lowered colonic KRT23 mRNA and protein expression.
These findings highlight a new regulatory mechanism by miR-195-5p in CRC affecting the keratin intermediate filaments and underline the miR-195-5p potential clinical properties.
背景/目的:KRT23最近被发现是I型角蛋白家族中的一种上皮特异性中间丝蛋白。许多研究强调了角蛋白参与多种生物学过程以及不同疾病的发病机制。具体而言,据报道KRT23会影响上皮细胞的结构完整性并触发导致癌症发生的细胞信号传导。本研究的目的是阐明基于miR-195-5p/KRT23在结直肠癌中的一种新机制。
在结直肠癌患者的福尔马林固定石蜡包埋切片中对KRT23 mRNA和蛋白表达进行特征分析。通过使用模拟物和抑制剂分子的瞬时转染实验评估miR-195-5p在mRNA和蛋白水平对KRT23表达的影响。在miR-195-5p模拟物转染后的人结直肠癌细胞系中评估细胞附着/脱离、迁移、侵袭、克隆形成和凋亡。
我们确定KRT23是miR-195-5p的一个假定靶点,miR-195-5p是一种我们之前证明在结直肠癌中表达降低的微小RNA。根据来自公共数据库的数据,我们证明与结直肠癌患者相邻正常黏膜相比,肿瘤切片中KRT23表达失调。我们证明miR-195-5p的增加会降低KRT23表达。相反,我们证明抑制miR-195-5p会导致KRT23表达水平升高。我们证明了miR-195-5p对结直肠癌进展的体外有效性,并且miR-195-5p模拟物的体内腹腔注射降低了结肠中KRT23 mRNA和蛋白表达。
这些发现突出了miR-195-5p在结直肠癌中影响角蛋白中间丝的一种新调控机制,并强调了miR-195-5p潜在的临床特性。